Literature DB >> 18825689

Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression.

S Azoulay1, S Terry, M Chimingqi, N Sirab, H Faucon, S Gil Diez de Medina, S Moutereau, P Maillé, P Soyeux, C Abbou, L Salomon, F Vacherot, A de La Taille, S Loric, Y Allory.   

Abstract

Recent studies have revealed the potential involvement of Hedgehog (Hh) signalling in proliferation and invasive behaviour of prostate carcinoma (PCa). The aim of this study was to specify the role of Sonic Hh (Shh), Desert Hh (Dhh) and Indian Hh (Ihh) in the natural history of PCa. Hh ligands expression was compared in primary hormone-naive PCa (HNPC), hormone-treated PCa (HTPC) and hormone-refractory PCa (HRPC), using immunohistochemistry. Shh and Dhh were expressed by both epithelial and stromal cells of prostate tissues. Ihh was only expressed by stromal cells. For the three ligands, mRNA and immunostaining were not correlated. In HNPC, Shh epithelial expression was significantly associated with high Gleason scores (p = 0.03), metastatic lymph nodes (p = 0.004) and Dhh epithelial staining was associated with high pT stages (p = 0.003), seminal vesicle invasion (p = 0.03) and bladder neck invasion (p = 0.0008). Negative Shh staining in stromal cells was associated with high Gleason scores (p = 0.015), high pT stages (p = 0.01) and bladder neck invasion (p = 0.04). Concomitant absence of Shh and Dhh expression in stromal cells was an independent prognostic parameter for biological recurrence on multivariate analysis (p = 0.01). Epithelial expression of Shh and Dhh was increased in HTPC compared to HNPC (p = 0.02 and p = 0.04). Interestingly, in vitro, transcript analysis also showed increased expression of these 2 Hh ligands when androgen-sensitive LNCaP cells were maintained in androgen-free medium mimicking hormonal therapy. Epithelial expression of Dhh was increased (p < 0.0001) in HRPC compared to HNPC, while stromal expression of Shh and Dhh was decreased (p < 0.0001). In conclusion, the Hh signalling pathway is associated with pejorative pathological parameters in HNPC and is up-regulated in epithelial cells of HTPC and HRPC. Moreover, the lack of Hh molecules in stromal cells seems to be associated with invasive and hormone-refractory behaviours and suggests specific changes in stromal-epithelial crosstalks during PCa progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18825689     DOI: 10.1002/path.2427

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  39 in total

1.  Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy.

Authors:  Guillaume Ploussard; Stéphane Terry; Pascale Maillé; Yves Allory; Nanor Sirab; Laurence Kheuang; Pascale Soyeux; Nathalie Nicolaiew; Estelle Coppolani; Bernard Paule; Laurent Salomon; Stéphane Culine; Ralph Buttyan; Francis Vacherot; Alexandre de la Taille
Journal:  Cancer Res       Date:  2010-11-02       Impact factor: 12.701

Review 2.  Hedgehog signaling in prostate epithelial-mesenchymal growth regulation.

Authors:  Yu-Ching Peng; Alexandra L Joyner
Journal:  Dev Biol       Date:  2015-01-29       Impact factor: 3.582

3.  Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells.

Authors:  Yiwei Li; Dejuan Kong; Zhiwei Wang; Aamir Ahmad; Bin Bao; Subhash Padhye; Fazlul H Sarkar
Journal:  Cancer Prev Res (Phila)       Date:  2011-06-16

4.  Design and Evolution of a Macrocyclic Peptide Inhibitor of the Sonic Hedgehog/Patched Interaction.

Authors:  Andrew E Owens; Ivan de Paola; William A Hansen; Yi-Wen Liu; Sagar D Khare; Rudi Fasan
Journal:  J Am Chem Soc       Date:  2017-08-30       Impact factor: 15.419

5.  Phosphodiesterase 4D inhibitors limit prostate cancer growth potential.

Authors:  Ginny L Powers; Kimberly D P Hammer; Maribella Domenech; Katsiaryna Frantskevich; Rita L Malinowski; Wade Bushman; David J Beebe; Paul C Marker
Journal:  Mol Cancer Res       Date:  2014-08-22       Impact factor: 5.852

6.  CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma.

Authors:  Rajarshi Sengupta; Adrian Dubuc; Stacey Ward; Lihua Yang; Paul Northcott; B Mark Woerner; Kirsten Kroll; Jingqin Luo; Michael D Taylor; Robert J Wechsler-Reya; Joshua B Rubin
Journal:  Cancer Res       Date:  2011-11-03       Impact factor: 12.701

7.  Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signalling.

Authors:  Vassiliki Tzelepi; Maria Karlou; Sijin Wen; Anh Hoang; Christopher Logothetis; Patricia Troncoso; Eleni Efstathiou
Journal:  Histopathology       Date:  2011-06       Impact factor: 5.087

8.  Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.

Authors:  Mengqian Chen; Michael A Feuerstein; Elina Levina; Prateek S Baghel; Richard D Carkner; Matthew J Tanner; Michael Shtutman; Francis Vacherot; Stéphane Terry; Alexandre de la Taille; Ralph Buttyan
Journal:  Mol Cancer       Date:  2010-04-26       Impact factor: 27.401

9.  Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma.

Authors:  Chad M McKee; Danmei Xu; Yunhong Cao; Sheheryar Kabraji; Danny Allen; Veerle Kersemans; John Beech; Sean Smart; Freddie Hamdy; Adrian Ishkanian; Jenna Sykes; Melania Pintile; Michael Milosevic; Theodorus van der Kwast; Gaetano Zafarana; Varune Rohan Ramnarine; Igor Jurisica; Chad Mallof; Wan Lam; Robert G Bristow; Ruth J Muschel
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

10.  Increased expression of class III beta-tubulin in castration-resistant human prostate cancer.

Authors:  S Terry; G Ploussard; Y Allory; N Nicolaiew; F Boissière-Michot; P Maillé; L Kheuang; E Coppolani; A Ali; F Bibeau; S Culine; R Buttyan; A de la Taille; F Vacherot
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.